- CH₣1.53bn
- CH₣1.60bn
- €391.95m
Brief: Polypeptide Is Said To Shortlist EQT, IDG For Next Bidding Round - Bloomberg News
Brief: Polypeptide Group Says It Is Conducting Review Of Strategic Options
PolyPeptide attracts takeover interest from EQT, KKR, Bloomberg News reports
Media: PolyPeptide Is Said to Attract Takeover Interest From EQT, KKR - Bloomberg News
Brief: Polypeptide Says Shareholders Approve All Board Proposals At AGM
Switzerland's PolyPeptide misses 2025 revenue estimates, expects margin improvement in 2026
Europe Research Roundup: Aixtron ,Vesuvius, Wacker Chemie
Brief: Polypeptide Group Ag - Full Year Revenue Eur 389 Million
Brief: Lupin Says Lupin Manufacturing Solutions, Polypeptide Announce Alliance
Brief: Polypeptide And Lupin Manufacturing Solutions Form Alliance To Meet Demand For Peptide Supply In Metabolic Therapies
Europe Research Roundup: Aixtron, Finecobank,TKH Group
Jefferies sees pressure on peptide manufacturers, initiates Novo with 'underperform'
Jefferies starts Novo Nordisk coverage at 'underperform' on rising competition
Brief: Polypeptide Group AG - Outlook 2025 Capital Expenditures EUR Around 100 Million
Europe Research Roundup: Airbus, Hermes, LVMH
Brief: PolyPeptide Announces Expansion Of Existing Credit Facilities
Brief: Polypeptide To Propose Peter Wilden For Re-Election As Chair Of Board Of Directors
Polypeptide at 1-year low after guidance undershoots expectations
Top of the Street: Big Yellow Group, Munich Re, Vestas, Geberit